Charles Carter
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles Carter
Charles Carter is recorded as CFO at Cero Therapeutics Holdings, Inc. (CERO). Cero Therapeutics Holdings, Inc. reported in an 8-K filed February 15, 2024 that Charles Carter was appointed Chief Financial Officer, effective February 14, 2024. The proxy statement of Cero Therapeutics Holdings, Inc. reports total compensation of $690,262 for Charles Carter in fiscal 2024, including a base salary of $218,750.
“Mr. Carter was appointed as the Company's Chief Financial Officer”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cero Therapeutics Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian G. Atwood CEO, Chairman
- Chris Ehrlich CEO, Chairman, Board Member
- Andrew Albert "Al" Kucharchuk CFO
- Andrew Albert Kucharchuk CFO
- Andrew Albert “Al” Kucharchuk CFO
- Daniel Corey CTO, Board Member
- Eric Francois Board Member
- Lindsey Rolfe Board Member
- Lindsey Rolfe, M.D. Board Member
- Michael Byrnes Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Cero Therapeutics Holdings, Inc. (CERO) | Former Chief Financial Officer Andrew “Al” Kucharchuk | $218,750 | $690,262 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.